Buying dividend stocks has proven to be a superior investing strategy. Because dividend payers tend to be large, successful businesses, they can better withstand the winds of market turmoil. Analysts at the Hartford Funds found that going as far back as 1930, stocks that initiated and raised their dividends handily beat all other stocks. Moreover, there was never a time when dividend stocks on the benchmark index had a losing decade. It just makes sense that being paid to own stocks and hold them for the lo ...

The Wall Street bloodbath intensified on Aug 5 on renewed fears of the U.S. economy slipping into a recession. The fears, which escalated on Friday, spread into the global markets and rattled stocks worldwide.The Dow plummeted 1,033.99 points, or 2.6%, to close at 38,703.27, posting its worst day in nearly two years. The S&P 500 declined 3% to finish at 5,186.33, while the tech-heavy Nasdaq, which entered correction territory last week, gave up another 3.4% to end at 16,200.08.Recession Fears Lead to Massiv ...

Core Viewpoint - Colgate-Palmolive Company reported strong second-quarter 2024 results, with both top and bottom lines exceeding expectations and showing year-over-year improvement, driven by robust sales growth and margin expansions [1][2][12] Financial Performance - Earnings per share on a Base Business basis were 91 cents, an 18% increase from the prior year, surpassing the Zacks Consensus Estimate of 87 cents [1] - Net sales reached $5.1 billion, a 4.9% increase from the previous year, beating the Zacks Consensus Estimate of $5,012 million, with organic sales growth of 9% [2][4] - Gross profit improved by 10% year over year to $3.07 billion, with a gross profit margin expansion of 280 basis points to 60.6% on a GAAP basis [5][6] Segment Performance - North America's net sales rose 2.5% year over year, driven by a 5.9% increase in volume, despite a 3.3% decline in pricing [7] - Latin America's net sales advanced 7.6% year over year, with 13.3% pricing gains and a 5.5% increase in volume, although impacted by an 11.2% unfavorable currency effect [8] - Europe’s net sales increased 6.2% year over year, supported by a 5.2% rise in volume and a 1.3% pricing gain [9] - Asia Pacific segment's net sales improved 2.6% year over year, reflecting a 3.4% increase in volume [10] - Africa/Eurasia's net sales rose 2.2% year over year, driven by an 8.4% increase in volume and 8% growth in pricing [11] Outlook - Management raised its organic sales and base business EPS forecasts for 2024, now expecting organic sales growth of 6-8% [12][13] - The company anticipates net sales growth of 2-5%, reflecting a higher organic sales view but increased negative currency impact [12] - Adjusted earnings per share are expected to increase by 8-11% for 2024, with double-digit growth anticipated on a GAAP basis [13]

Key TakeawaysColgate-Palmolive surpassed analysts' expectations with its second-quarter revenue and earnings per share. The company raised its full-year organic sales growth projections.Each of Colgate-Palmolive's operating divisions generated positive volume growth.The stock climbed Friday, leaving it within range of a record close. Colgate-Palmolive Company (CL) beat expectations on the top and bottom lines with its second-quarter results Friday, sending its shares toward record highs. The consumer produc ...

Colgate-Palmolive Company (NYSE:CL) Q2 2024 Earnings Conference Call July 26, 2024 8:30 AM ET Company Participants Noel Wallace - President, Chief Executive Officer Stan Sutula - Chief Financial Officer John Faucher - Chief Investor Relations Officer Conference Call Participants Peter Grom - UBS Dara Mohsenian - Morgan Stanley Filippo Falorni - Citi Andrea Teixeira - JP Morgan Robert Moskow - TD Cowen Bonnie Herzog - Goldman Sachs Chris Carey - Wells Fargo Olivia Tong - Raymond James Steve Powers - Deutsch ...

Core Insights - Colgate-Palmolive reported revenue of $5.06 billion for the quarter ended June 2024, reflecting a year-over-year increase of 4.9% and surpassing the Zacks Consensus Estimate of $5.01 billion by 0.93% [1] - The company's EPS for the quarter was $0.91, up from $0.77 in the same quarter last year, exceeding the consensus EPS estimate of $0.87 by 4.60% [1] Revenue Performance by Region - North America: Net sales of $1 billion, a 2.5% increase year-over-year, below the average estimate of $1.01 billion [2] - Latin America: Net sales of $1.27 billion, a 7.6% increase year-over-year, slightly below the average estimate of $1.30 billion [2] - Africa/Eurasia: Net sales of $273 million, a 1.9% increase year-over-year, exceeding the average estimate of $247.25 million [2] - Europe: Net sales of $720 million, a 6.2% increase year-over-year, above the average estimate of $709.41 million [2] - Asia Pacific: Net sales of $682 million, a 2.7% increase year-over-year, surpassing the average estimate of $649.87 million [2] - Pet Nutrition: Net sales of $1.11 billion, a 5.5% increase year-over-year, slightly above the average estimate of $1.10 billion [2] - Total Oral, Personal and Home Care: Net sales of $3.94 billion, a 4.7% increase year-over-year, exceeding the average estimate of $3.92 billion [2] Operating Profit - Total Oral, Personal and Home Care: Operating profit of $1.06 billion, above the average estimate of $1.04 billion [2] - Corporate: Operating profit of -$201 million, worse than the average estimate of -$168.56 million [2] - Pet Nutrition: Operating profit of $235 million, exceeding the average estimate of $211.17 million [2] Stock Performance - Colgate-Palmolive shares have returned -1.7% over the past month, compared to the Zacks S&P 500 composite's -1.2% change, with a current Zacks Rank of 3 (Hold) indicating potential performance in line with the broader market [3]

Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.60%. A quarter ago, it was expected that this consumer products maker would post earnings of $0.82 per share when it actually produced earnings of $0.86, delivering a surprise of 4.88%.Over the last four quarters ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________ FORM 10-Q ________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to________ . Commission File Number: 1-644 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as spe ...

COLGATE-PALMOLIVE COMPANY 2Q 2024 EARNINGS PRESENTATION JULY 26, 2024 July 2024 Notice for Investor Presentation Please review the following second quarter 2024 earnings presentation in conjunction with our second quarter 2024 earnings press release, our second quarter 2024 prepared management remarks, our second quarter 2024 Quarterly Report on Form 10-Q and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Cent ...

Exhibit 99 Colgate Announces 2nd Quarter 2024 Results • Net sales increased 4.9%; Organic sales* increased 9.0% • GAAP EPS increased 48% to $0.89; Base Business EPS* increased 18% to $0.91 • GAAP Gross profit margin increased 280 basis points to 60.6%; Base Business Gross profit margin* increased 300 basis points to 60.8% • Net cash provided by operations was $1,671 million for the first six months of 2024 • Colgate's leadership in toothpaste continued with its global market share at 41.5% year to date • Co ...